National Health Investors executives have sold $100 million of debt to a private placement lender. The money raised was split evenly between eight-year notes with a coupon of 3.99 percent and 10-year notes paying 4.33 percent. Both series are unsecured and were used to pay down debt on NHI's $550 million revolving credit line, which is the company's (Ticker: NHI) only debt with a variable interest rate.
Hours after abandoning its audacious bid to buy TeamHealth, AmSurg has announced that its physician services division is acquiring a large anesthesiology practice in Phoenix. Valley Anesthesiology & Pain Consultants is home to about 280 doctors and allied care providers and works at 21 hospitals, 25 surgery centers and a number of doctors' offices in the Phoenix market.
Also still on the M&A path is long-term care provider Diversicare. The Brentwood-based company has paid $3.9 million for a 60-bed skilled nursing center in Fulton, Kentucky. The deal grows Diversicare's holdings to 12 in Kentucky and 55 in total.
Shares of Genesco are getting a boost today thanks to C.L. King analyst Steven Marotta, who has hiked his rating on the Nashville-based company to 'strong buy' from 'buy.' As of 11:10 a.m., Genesco (Ticker: GCO) was up almost 5 percent to $60.65. The shares are still down about 20 percent year to date, though.
Brookdale Senior Living stock is headed in the other direction today, thanks to Kevin Fischbeck at Bank of America Merrill Lynch's downgrade of the company to 'neutral.' Fischbeck's call comes a day after Brian Tanquilut at Jefferies trimmed his price target for Brookdale to $40 from $44. Late this morning, Brookdale (Ticker: BKD) was trading at $23 and change.
And lastly, Roger Read at Wells Fargo has grown more constructive on several parts of the energy sector. That led him to lift his ratings this week on Delek US Holdings and other oil refiners to 'outperform' from 'market perform.' Delek shares (Ticker: DK) are up slightly Thursday to about $27.50 and are flat year to date.
National HealthCare Corp. and Bank of America have agreed to a new $175 million line of credit that will replace the companies' $75 million deal, which was to have expired Oct. 21. NHC CEO Robert Adams says the new line will let his team complete the roughly $170 million redemption of their preferred shares while continuing to invest in their regular businesses. The credit line will mature on five years.
Shares of Murfreesboro-based NHC (Ticker: NHC) are changing hands this morning around $63.30, flat on the day and for the year.
POSTDATA: WARRANTY DEEDS